Watch · Quality 90/100
Simple research view
AZN · AstraZeneca PLC
$189.28 latest stored close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$AZN
AstraZeneca PLCAstraZeneca PLC is a mega-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $215B.
Council read · 6 methods
Watch — evidence is building
0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.
Earnings-risk mode
Post-earnings setup
Monday, July 27, 2026
Time not confirmed
No sourced report session or clock time
Deterministic evidence
AZN-1.99%
CatalystUnavailable
Stock reactionNegative
Sector reactionUnavailable
Opening surgeUnavailable
Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.AZN Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Setup Quality
B
4/7 signals
Score trend
✓
Stage 2 · Advancing
✗
Power Trend 4d
✗ RS New High
✓ Trend 8/8
✗
No Pattern
✓ CANSLIM 73.7 (B)
✓ Gatekeeper
Base #1 (A)
Technical Analysis Report Card
$AZN · $189.28 · as of 2026-07-08 · multi-factor read
76
/ 100
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▬ Sideways / consolidating
Monthly
▬ Sideways / consolidating
Moving Averages
50-day$184.11 ↑
100-day$191.12 ↓
200-day$143.61 ↑
Bullish (50 > 200)
RSI (14)
Reading54.0 · Neutral
Neutral — momentum is balanced between buyers and sellers.
MACD (12/26/9)
StateBullish
Histogram+1.189
Bullish — MACD above its signal line and above zero. Histogram contracting.
Bollinger Bands (20,2)
%B / Width72% · 13.1%
Mid-band — no directional band edge in play.
Volume · Buyer vs Seller
Up/Down vol0.98 · Neutral
Rel volume0.96×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.
Support & Resistance
R · $191.50swing level
R · $207.30swing level
R · $209.93swing level
Price · $189.28now
S · $181.33swing level
S · $174.12swing level
S · $89.34swing level
Fibonacci · Uptrend swing
23.6%$183.52
38.2%$165.47
50.0%$150.88
61.8%$136.28
78.6%$115.51
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for AZN — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Above 200-day MA50/200 bullishRS 97 (leader)
Want this read in a legend's voice?
💬 Ask a Legend about AZN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B
Trend-template read: 10/12 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $189.28, MA150 $163.41, MA200 $143.61
1.2 150-day MA > 200-day MAMA150 $163.41 vs MA200 $143.61
Failing evidence
2. Quarterly EPS growth ≥ 25%+21.7% QoQ
2. Revenue growth ≥ 20% YoY+9.9% YoY
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 98
A: Annual earnings & revenue qualityRev +9.9% | ROE 22.3%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+21.7% QoQ
S: Volume ≥ 40% above average on breakoutVolume ratio 0.96x
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $189.28 vs MA200 $143.61
Failing evidence
Volume expansion above averageVolume ratio 0.96x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$189.28
Relative strengthRS 98
Failing evidence
Volume vs average0.96x
Pivotal point cleared on expanding volumeNot confirmed
Watch
Darvas B
Box-theory read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$189.28
Relative strengthRS 98
Failing evidence
Volume vs average0.96x
Box top broken on heavy volumeNot confirmed
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$189.28
Relative strengthRS 98
Failing evidence
Volume vs average0.96x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
Breakout Health
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
🕯 Latest candle: Shooting Star — Long upper shadow with a small body near the low — sellers rejected higher prices. A caution flag when price is extended above a pivot.
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net -6
Fundamentals & leadership quality — Minervini SEPA criteria · 5/7 met
B
5/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+22%
Revenue growth ≥20% YoY
+10%
Gross margin ≥30%
81%
ROE ≥17%
22%
RS rating ≥80 (leadership)
98
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-11.0%
Method Playbook
📋 Trade it like Darvas
EXACT LEVELS · PRO
Darvas B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis (historical · 19d ago)
89.8
score
RS Score
98
Trend
8/8 ✓
CANSLIM
73.7* (B)
depth pct: 11.7
base days: 51
prior uptrend pct: 112.7
weekly close spread pct: 9.0
vol dried: ✓
validation reason: valid generic setup
multi tf reason: weekly trend template 8/8 confirmed
Why This Setup?
Flat Base
Flat Base: 51d base, depth 11.7%, prior uptrend 113%. Pivot $196.64. | Strong trend (8/8) | Top RS (98) | High-confidence pattern (85%) | Stage 2 | Readiness 65/100 (watch) | CANSLIM 73.7 (B)
The Universal Edge Check
The panel is uneasy
Too many universals unmet — this leans closer to a guess than a trade.
2/7
universals met
- In a confirmed uptrend Stage 2 · Trend 8/8
- Risk is defined No stop — undefined risk
- Asymmetric reward No target set
- Not chasing (in range) Pivot distance unknown
- Volume confirms 1.0× average — light
- Clear of earnings in -1 days — event risk
- A relative-strength leader RS 99
Minervini Trend Template
8/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$189.28 vs SMA150 $163.41 / SMA200 $143.61
SMA 150 above SMA 200
SMA150 $163.41 vs SMA200 $143.61
SMA 200 trending up
Slope +10.39 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $184.11
Price above SMA 50
$189.28 vs SMA50 $184.11
30%+ above 52W low
+175.9% from $68.61
Within 25% of 52W high
-11.0% from $212.71
RS score above 70
RS 98
Fundamentals
52W Range
84%
Mkt Cap SEC
214.9B
EPS QoQ
+22%
Rev YoY
+10%
ROE
22%
Gross Margin
81%
D/E
0.61
EPS TTM
$6.65
P/E TTM
28.4x
Insider
No Buy
Company
Legend AI snapshot
AstraZeneca PLC
$189.28latest close
$214.9Bmarket cap
99RS rank
90setup score
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
73.7* CANSLIM
* disqualified on C, M
C · Curr. EPS
88
A · Annual EPS
76
N · New Highs
40
S · Supply/Demand
70
L · Leader RS
98
I · Inst. Spons.
100
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
98
W. Support
$89.04
W. Resist
$212.71
Weekly Structure
Trend
Neutral
Tight Weeks
1
Confirmation
Neutral
Scan History
Jul 09
Flat Base
✓ Gate
90
Jul 08
Flat Base
✓ Gate
91
0.0%
Jul 07
Flat Base
✓ Gate
90
-2.0%
Jul 06
Base Breakout
✓ Gate
92
-0.5%
Jul 03
Flat Base
90
-0.5%
Jul 02
Flat Base
90
-3.0%
Get the full picture on AZN
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.
Start 7-Day Free Trial